CNS Peptides in Huntington’s Chorea

  • P. C. Emson
  • D. Dawbarn
  • M. E. de Quidt
Conference paper
Part of the Advances in Applied Neurological Sciences book series (NEUROLOGICAL, volume 4)


Huntington’s chorea is a hereditary disease inherited as an autosomal dominant gene which produces progressive degeneration of the basal ganglia and, in particular, the caudate nucleus and putamen. As these CNS regions in other mammals are particularly rich in neuropeptides such as substance P and methionine-enkephalin, it was logical to look at the content of these peptides in Huntington’s disease to see if they could be used as biochemical markers for the degenerative changes characterizing this condition (see [5]).


Basal Ganglion Glutamic Acid Decarboxylase Major Cell Type Autosomal Dominant Gene Lateral Globus Pallidus 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Aronin N, Cooper PE, Lorenz LJ, Bird ED, Sagar SM, Leeman SE, Martin JB (1983) Somatostatin is increased in the basal ganglia in Huntington’s disease. Ann Neurol 13: 519–526PubMedCrossRefGoogle Scholar
  2. 2.
    Bird ED, Iversen LL (1974) Huntington’s chorea. Postmortem measurement of glutamic acid decarboxylase, choline acetyltransferase and dopamine in basal ganglia. Brain 97: 457–472PubMedCrossRefGoogle Scholar
  3. 3.
    Dawbarn D, De Quidt ME, Emson PC (1985) Survival of basal ganglia neuropeptide Ysomatostatin neurones in Huntington’s disease. Brain Res 340: 251–260PubMedCrossRefGoogle Scholar
  4. 4.
    Dawbarn D, Zamir N, Waters CM, Hunt SP, Emson PC, Brownstein MJ (1986) Decreased dynorphin-like immunoreactivity in Huntington’s disease. Brain Res 372: 155–158PubMedCrossRefGoogle Scholar
  5. 5.
    Emson PC (1986) Neuropeptides and the pathology of Huntington’s disease. In: Emson PC, Rossor MR, Tohyama M (eds) Peptides and neurological disease. Elsevier/North-Holland, Amsterdam. Progress in Brain Research, vol 66, pp 91–105Google Scholar
  6. 6.
    Emson PC, Arregui A, Clement-Jones V, Sandberg BEB, Rossor M (1980) Regional distribution of methionine-enkephalin and substance P-like immunoreactivity in normal human brain and in Huntington’s disease. Brain Res 199: 147–160PubMedCrossRefGoogle Scholar
  7. 7.
    Graybiel AM (1984) Neurochemically specified subsystems in the basal ganglia. In: Evered D, O’Connor M (eds) CIBA Foundation Symposium 107: 114–149Google Scholar
  8. 8.
    Gusella JF, Wexler NS, Conneally PM, Naylor SL, Anderson MA, Tanzi RE, Watkins PC, Othna K, Wallace MR, Sagaguchi AY, Young AB, Shoulson I, Bonilla E, Martin JB (1983) A polymorphic DNA marker genetically linked to Huntington’s disease. Nature 306: 234–238PubMedCrossRefGoogle Scholar
  9. 9.
    Höllt V (1985) Multiple endogenous opioid peptides. In: Bousfield D (ed) Neurotransmitters in action. Elsevier Biomedical, Amsterdam, pp 188–193Google Scholar
  10. 10.
    Jessell TM (1983) Substance P. In: Iversen LL, Iversen SD, Snyder SH (eds) Handbook of Psychopharmacology. Plenum, New York, vol 16, pp 1–56Google Scholar
  11. 11.
    Nawa H, Hirose T, Takashima H, Inagama S, Nakanishi S (1983) Nucleotide sequences of clones cDNA for two types of bovine brain substance P precursor. Nature 306: 32–36PubMedCrossRefGoogle Scholar
  12. 12.
    Rossor M, Emson PC (1982) Neuropeptides in degenerative disease of the central nervous system. Trends in Neurosci 5: 399–341CrossRefGoogle Scholar
  13. 13.
    Thomas E, Pearse AGE (1964) The solitary active cells’ histochemical demonstration of damage resistant nerve cells with a TPN-diaphorase reaction. Acta Neuropathol 3: 238–249PubMedCrossRefGoogle Scholar
  14. 14.
    Vincent SR, Johansson O, Hökfelt T, Skirboll L, Elde RP, Terenius L, Kimmel J, Goldstein M (1983) NADPH-diaphorase: a selective histochemical marker for striatal neurones containing both somatostatin-and avian pancreatic polypeptide ( APP)-like immunoreactivities. J Comp Neurol 217: 252–263PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1987

Authors and Affiliations

  • P. C. Emson
    • 1
  • D. Dawbarn
    • 1
  • M. E. de Quidt
    • 1
  1. 1.Department of Neuroendocrinology, Institute of Animal PhysiologyMRC GroupBabraham, CambridgeUK

Personalised recommendations